Trial reportScientific reports2025
Indirect calorimetry and nitrogen balance guided nutrition therapy in ICU patients with acute kidney injury.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Data on the benefits of early integration of indirect calorimetry (IC) for caloric guidance and maintaining a positive nitrogen balance in critically ill patients with acute kidney injury (AKI) are scarce. This study aimed to evaluate the impact of the nutritional therapeutic approach on mortality and renal outcomes in these patients. We conducted an open-label randomized controlled trial, Intensive Care Unit (ICU)-admitted patients on mechanical ventilation who were diagnosed with AKI within 72 h after admission were enrolled and assigned to receive either early goal nutrition therapy (caloric dosing guided by IC and protein delivery guided by nitrogen balance, maximum 1.3 g/kg/day) or conventional nutrition therapy for 14 days. The primary outcome was all-cause 28-day mortality. Secondary outcomes included 14-day mortality, an incidence of renal replacement therapy (RRT) initiation, and safety. A total of 80 patients were enrolled, with 40 participants in each group. At 28 days, mortality in the early goal group was 17.5% (7 out of 40), compared to 40% (16 out of 40) in the conventional group, resulting in a difference of 22.5% points (P = 0.03). The incidence of RRT initiation and adverse events was similar. In conclusion, among critically ill patients with AKI, early goal nutrition therapy is safe. However, renal and mortality outcomes do not allow for a conclusion since the unequal in disease severity between groups. Larger randomized controlled trials are required to confirm findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.